🟢 Ocugen is trading 8% up today ahead of September 24 OCU410ST and OCU410 presentations

Ocugen is trading 8.03% up at MXN 18.44 as investors anticipate clinical presentations scheduled for September 24, 2026, at The Retina Society.

• The company is scheduled to present Phase 1 OCU410ST safety and tolerability data.
• It will also present 12-month Phase 2 ArMaDa results for OCU410.
• No new results were available during the current session, so the move appears driven by anticipation of the scheduled readouts.